Gene therapy that targeted muscle disease did not require immunotherapy which would greatly reduce the cost and side effects of treatment
One method for gene therapy that targets problem genes in muscles did not require immunotherapy treatment. Removing the need for immunotherapy while still having effective gene therapy greatly reduces the cost and side effects of gene therapy. Journal of Clinical Investigation – Human Treg responses allow sustained recombinant adeno-associated virus–mediated transgene expression Recombinant adeno-associated virus …